These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28412806)

  • 1. [Correlation between Alzheimer disease and cataract].
    Liu SS; Zhu SQ
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):314-316. PubMed ID: 28412806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.
    Tian T; Zhang B; Jia Y; Li Z
    Dis Markers; 2014; 2014():826503. PubMed ID: 24688166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging ocular biomarkers of Alzheimer disease.
    van Wijngaarden P; Hadoux X; Alwan M; Keel S; Dirani M
    Clin Exp Ophthalmol; 2017 Jan; 45(1):54-61. PubMed ID: 28147442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A test of lens opacity as an indicator of preclinical Alzheimer Disease.
    Bei L; Shui YB; Bai F; Nelson SK; Van Stavern GP; Beebe DC
    Exp Eye Res; 2015 Nov; 140():117-123. PubMed ID: 25773986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions.
    Dehghani C; Frost S; Jayasena R; Masters CL; Kanagasingam Y
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3554-3563. PubMed ID: 30025102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cataract, Alzheimer's disease, and other conformational diseases.
    Harding JJ
    Curr Opin Ophthalmol; 1998 Feb; 9(1):10-3. PubMed ID: 10178625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease.
    Michael R; Rosandić J; Montenegro GA; Lobato E; Tresserra F; Barraquer RI; Vrensen GF
    Exp Eye Res; 2013 Jan; 106():5-13. PubMed ID: 23142516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-amyloid expression in age-related cataract lens epithelia and the effect of β-amyloid on oxidative damage in human lens epithelial cells.
    Xu J; Li D; Zheng T; Lu Y
    Mol Vis; 2017; 23():1015-1028. PubMed ID: 29386875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study.
    Michael R; Otto C; Lenferink A; Gelpi E; Montenegro GA; Rosandić J; Tresserra F; Barraquer RI; Vrensen GF
    Exp Eye Res; 2014 Feb; 119():44-53. PubMed ID: 24333259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the lens model provide a biomarker for Alzheimer's disease?
    Tian T; Zhang B; Jia Y; Li Z
    Brain Pathol; 2013 Nov; 23(6):696. PubMed ID: 24118485
    [No Abstract]   [Full Text] [Related]  

  • 13. Dementia in 2014. Towards early diagnosis in Alzheimer disease.
    Nordberg A
    Nat Rev Neurol; 2015 Feb; 11(2):69-70. PubMed ID: 25623789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
    Asih PR; Chatterjee P; Verdile G; Gupta VB; Trengove RD; Martins RN
    Neurodegener Dis Manag; 2014; 4(5):363-78. PubMed ID: 25405650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
    Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
    Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.
    Scheinin NM; Scheinin M; Rinne JO
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):265-79. PubMed ID: 21532540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.
    Galozzi S; Marcus K; Barkovits K
    Expert Rev Proteomics; 2015 Aug; 12(4):343-54. PubMed ID: 26153725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's and Danish dementia peptides induce cataract and perturb retinal architecture in rats.
    Reddy GB; Reddy PY; Surolia A
    Biomol Concepts; 2017 Mar; 8(1):45-84. PubMed ID: 28222009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.
    Morris GP; Clark IA; Vissel B
    Acta Neuropathol; 2018 Nov; 136(5):663-689. PubMed ID: 30349969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemistry of Alzheimer Disease Amyloid Beta Peptides.
    Chiorcea-Paquim AM; Enache TA; Oliveira-Brett AM
    Curr Med Chem; 2018; 25(33):4066-4083. PubMed ID: 29446720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.